ATE137967T1 - Verwendung von ketorolac zur behandlung von periodontitis - Google Patents

Verwendung von ketorolac zur behandlung von periodontitis

Info

Publication number
ATE137967T1
ATE137967T1 AT91906055T AT91906055T ATE137967T1 AT E137967 T1 ATE137967 T1 AT E137967T1 AT 91906055 T AT91906055 T AT 91906055T AT 91906055 T AT91906055 T AT 91906055T AT E137967 T1 ATE137967 T1 AT E137967T1
Authority
AT
Austria
Prior art keywords
ketorolac
treat periodontitis
periodontitis
treat
prevention
Prior art date
Application number
AT91906055T
Other languages
English (en)
Inventor
Gary Robert Kelm
Harvey Marvin Pickrum
Matthew Joseph Doyle
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE137967T1 publication Critical patent/ATE137967T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT91906055T 1990-03-16 1991-03-01 Verwendung von ketorolac zur behandlung von periodontitis ATE137967T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49469790A 1990-03-16 1990-03-16
US65106191A 1991-02-08 1991-02-08

Publications (1)

Publication Number Publication Date
ATE137967T1 true ATE137967T1 (de) 1996-06-15

Family

ID=27051510

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91906055T ATE137967T1 (de) 1990-03-16 1991-03-01 Verwendung von ketorolac zur behandlung von periodontitis

Country Status (14)

Country Link
EP (1) EP0519983B1 (de)
JP (1) JP3140050B2 (de)
AT (1) ATE137967T1 (de)
AU (1) AU661818B2 (de)
BR (1) BR9106166A (de)
CA (1) CA2077693C (de)
DE (1) DE69119588T2 (de)
DK (1) DK0519983T3 (de)
ES (1) ES2086536T3 (de)
GR (1) GR3019928T3 (de)
IE (1) IE910886A1 (de)
NZ (1) NZ237449A (de)
SG (1) SG54157A1 (de)
WO (1) WO1991013609A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac
DE4300697C1 (de) * 1993-01-13 1994-05-19 Roemmers Sa Keterolac-Derivat mit wesentlich geringerer gastrointestinaler Reizung und Ulzeration
US5626838A (en) * 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
US5807541A (en) * 1996-04-22 1998-09-15 Sepracor, Inc. NSAID/fluoride periodontal compositions and methods
BRPI0302736B8 (pt) 2003-06-02 2021-05-25 Ems S/A composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
US7732478B2 (en) 2004-01-09 2010-06-08 The Trustees Of Columbia University In The City Of New York Methods for facilitating metabolic control

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2315948A1 (fr) * 1975-07-04 1977-01-28 Gaba Ag Produits pour l'hygiene de la bouche et des dents
US4919939A (en) * 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
ZA886757B (en) * 1987-09-11 1990-05-30 Syntex Inc Preservative system for ophthalmics formulations
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease

Also Published As

Publication number Publication date
DE69119588D1 (de) 1996-06-20
EP0519983A4 (en) 1993-03-10
ES2086536T3 (es) 1996-07-01
GR3019928T3 (en) 1996-08-31
EP0519983B1 (de) 1996-05-15
AU661818B2 (en) 1995-08-10
NZ237449A (en) 1996-10-28
JP3140050B2 (ja) 2001-03-05
DE69119588T2 (de) 1996-11-21
CA2077693A1 (en) 1991-09-17
AU7472991A (en) 1991-10-10
IE910886A1 (en) 1991-09-25
EP0519983A1 (de) 1992-12-30
BR9106166A (pt) 1993-03-16
JPH05505400A (ja) 1993-08-12
WO1991013609A1 (en) 1991-09-19
SG54157A1 (en) 1998-11-16
DK0519983T3 (da) 1996-10-14
CA2077693C (en) 1997-03-04

Similar Documents

Publication Publication Date Title
DE69621012D1 (de) VERWENDUNG VON NSAIDs ZUR BEHANDLUNG VON PLATTENEPITHELKARZINOM DER MUNDHÖHLE UND KEHLKOPF
BR9105531A (pt) Composicao oral anticalculo e processo para tratar dentes
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
FI900052A7 (fi) Koostumuksia ja hoitomenetelmiä peräpukamia ja muita varten
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DE3775805D1 (de) Arzneimittel zur behandlung periodontaler erkrankungen.
BG102526A (bg) Твърди дозирани форми, съдържащи флурбипрофен
ATE139445T1 (de) Verwendung von zinkionen zur behandlung der periodontitis
FI963687A0 (fi) Hygieeniset ja kosmeettiset valmisteet ihosairauksien estämiseksi ja hoitamiseksi sekä menetelmä niiden valmistamiseksi
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
KR950702405A (ko) 구강 조성물(oral compositions)
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
ATE82127T1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
ATE137967T1 (de) Verwendung von ketorolac zur behandlung von periodontitis
BG105275A (en) Tan-1057 derivatives
ATE142875T1 (de) Methode zur behandlung von haarausfall
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE3867634D1 (de) Neue zahnaertztliche zubereitung und verfahren zur herstellung.
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
HUP9900007A2 (hu) Készítmény baromfialom kezelésére
ATE211650T1 (de) Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen
DE69820911D1 (de) Verwendung einer Verbindung zur Herstellung eines Medikaments zur Behandlung von Alopecia oder zur Förderung des Haarwuchses bei Tieren
SE8004592L (sv) Tandkrem
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee